A Prospective, Phase 2a Study to Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts) in Subjects Ages 18 – 65 Years

ID Number 16-1101

Principal Investigator(s)
Andrew Alexis

Department(s) or Division(s)


This study is looking at the effectiveness of an investigational drug in the treatment of common warts. This includes warts on the hands and feet but NOT genital warts.

Patients must be in good health, ages 18-65 years. Patients must be available for weekly appointments. The study lasts 3-6 months. Criteria for entry apply. Patients may be compensated for their time and travel expenses.

Contact Information
Bridget Kaufman
(212) 523-4511

Recruiting Patients: Yes